396
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Treatment of severe hypertension during pregnancy: we still do not know what the best option is

, , , , &
Pages 25-32 | Received 15 Jun 2019, Accepted 15 Dec 2019, Published online: 27 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katherine A. Muldoon, Cheynne McLean, Darine El-Chaár, Daniel J. Corsi, Natalie Rybak, Amarjargal Dagvadorj, Yanfang Guo, Ruth Rennicks White, Alysha L. J. Dingwall-Harvey, Laura M. Gaudet, Mark C. Walker & Shi Wu Wen. (2023) Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation. The Journal of Maternal-Fetal & Neonatal Medicine 36:1.
Read now
Hui-Zhen Wu, Yuan Cheng, Ding Yu, Ji-Bin Li, Yun-Fa Jiang & Zhong-Ning Zhu. (2022) Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. Hypertension in Pregnancy 41:2, pages 126-138.
Read now

Articles from other publishers (3)

Allison M. Davis, Christina T. Blanchard, Akila Subramaniam, Rachel G. Sinkey, Alan T. Tita & Ashley N. Battarbee. (2023) Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum. Obstetrics & Gynecology.
Crossref
Nian-Jia Deng, Chen-Yang Xian-Yu, Rui-Zheng Han, Cheng-Yang Huang, Yu-Tong Ma, Hui-Jun Li, Teng-Yu Gao, Xin Liu & Chao Zhang. (2023) Pharmaceutical administration for severe hypertension during pregnancy: Network meta-analysis. Frontiers in Pharmacology 13.
Crossref
Michalina Bralewska, Lidia Biesiada, Mariusz Grzesiak, Magda Rybak-Krzyszkowska, Hubert Huras, Agnieszka Gach, Tadeusz Pietrucha & Agata Sakowicz. (2021) Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy. BMC Pregnancy and Childbirth 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.